These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32372435)

  • 1. Drug repurposing in the era of COVID-19: a call for leadership and government investment.
    Martin JH; Bowden NA
    Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435
    [No Abstract]   [Full Text] [Related]  

  • 2. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
    Abbasi J
    JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid repurposing of drugs for COVID-19.
    Guy RK; DiPaola RS; Romanelli F; Dutch RE
    Science; 2020 May; 368(6493):829-830. PubMed ID: 32385101
    [No Abstract]   [Full Text] [Related]  

  • 5. Boosting the arsenal against COVID-19 through computational drug repurposing.
    Ciliberto G; Cardone L
    Drug Discov Today; 2020 Jun; 25(6):946-948. PubMed ID: 32304645
    [No Abstract]   [Full Text] [Related]  

  • 6. Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
    Alonso DF; Farina HG
    Int J Antimicrob Agents; 2020 Sep; 56(3):106125. PubMed ID: 32739476
    [No Abstract]   [Full Text] [Related]  

  • 7. α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19.
    Williams SJ; Goddard-Borger ED
    Biochem Soc Trans; 2020 Jun; 48(3):1287-1295. PubMed ID: 32510142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
    Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N
    J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teaching Old Drugs New Tricks: Statins for COVID-19?
    Fajgenbaum DC; Rader DJ
    Cell Metab; 2020 Aug; 32(2):145-147. PubMed ID: 32755604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panic prescribing has become omnipresent during the COVID-19 pandemic.
    Caplan AL; Upshur R
    J Clin Invest; 2020 Jun; 130(6):2752-2753. PubMed ID: 32330122
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19: A Defining Moment for Clinical Pharmacology?
    van der Graaf PH; Giacomini KM
    Clin Pharmacol Ther; 2020 Jul; 108(1):11-15. PubMed ID: 32350861
    [No Abstract]   [Full Text] [Related]  

  • 13. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.
    Saini KS; Lanza C; Romano M; de Azambuja E; Cortes J; de Las Heras B; de Castro J; Lamba Saini M; Loibl S; Curigliano G; Twelves C; Leone M; Patnaik MM
    Br J Cancer; 2020 Sep; 123(5):694-697. PubMed ID: 32572174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
    Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
    Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines: A Call for Research Studies.
    Ruiz de Pellón Santamaría Á
    J Clin Psychopharmacol; 2020; 40(6):641-642. PubMed ID: 33136928
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. East meets West in COVID-19 therapeutics.
    Wang S; Zeng X; Wang Y; Zhao Y; Chen W; Chen YZ
    Pharmacol Res; 2020 Sep; 159():105008. PubMed ID: 32531323
    [No Abstract]   [Full Text] [Related]  

  • 18. Combating devastating COVID-19 by drug repurposing.
    Pawar AY
    Int J Antimicrob Agents; 2020 Aug; 56(2):105984. PubMed ID: 32305589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic drugs and COVID-19.
    Brenna OV; Torretta S; Pignataro L; Di Berardino F
    Int J Immunopathol Pharmacol; 2020; 34():2058738420966078. PubMed ID: 33045858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
    Chakraborti S; Bheemireddy S; Srinivasan N
    Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.